Sakar Healthcare schedules a February 5, 2026 Board meeting to approve unaudited Q3 FY2025 results (standalone and consolidated), with insider-trading window restrictions remaining in force until results are released.
AI Assistant
Sakar Healthcare Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.